Lupus kliniske forsøg i New Jersey
6 studier for Lupus søger deltagere på steder i New Jersey.
Byer i New Jersey
Officiel studietekst (engelsk)
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, West Long Branch
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 25. sep. 2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Rutgers New Jersey Medical School, Newark
- Arthritis Rheumatic And Back Disease Associates, Voorhees Township
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07438496Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Astera Cancer Care, East Brunswick
RekruttererFase 1
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Sahni Rheumatology & Therapy, West Long Branch
RekruttererObservationsstudie
Alder 16 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07175285Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Hackensack Meridian Health, Hackensack
RekruttererFase 3
Alder 55 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT05799378Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.